Navigation Links
Competitive Technologies Selects RF|Binder as Public Relations Agency of Record
Date:11/5/2009

NEW YORK, Nov. 5 /PRNewswire/ -- RF|Binder Partners today announced that it has been engaged by Competitive Technologies, Inc. (NYSE Amex: CTT) to help roll out and promote it's Calmare Therapy Treatment*, an FDA-approved, non-invasive pain management medical device for treating high-intensity oncologic and neuropathic pain, including pain resistant to morphine and other drugs. CTT is working to expand awareness of the brand and electromedical technology among medical professionals, hospitals and the general public. RF|Binder has strong experience among healthcare, pharmaceutical and technology clients.

"We chose RF|Binder because they exhibited a genuine interest and awareness in our space, and a strategic understanding of our business plan and objectives," said John Nano, CTT's Chairman, President and CEO. "Our Calmare Therapy Treatment has full FDA clearance for marketing here in the U.S., is currently in use in Europe and has proven to be an effective alternative to harmful narcotic painkillers, with no adverse side effects. We look forward to working with RF|Binder to increase the exposure of Calmare and to promote the growth and success of the brand."

Calmare has received U.S. FDA 510(k) clearance for U.S. sales and medical device CE certification from the European Union. The innovative technology provides pain control and relief using a unique, non-invasive biophysical process that has been clinically tested and proven with thousands of patients. Unlike drugs, continued treatments can help to steadily diminish the intensity of the pain. The Calmare Therapy Treatment is effective in a high percentage of cases for patients with acute and chronic pain. The product has recently been selected for use at the Paul Carbone Cancer Center at University of Wisconsin-Madison, the University of Miami Pain Management Center and the Massey Cancer Center at Virginia Commonwealth University as well as at La Sapienza University of Rome.

"We're pleased to be working with CTT and its breakthrough technology in pain management," said Robert Ferris, Executive Managing Director at RF|Binder Partners. "Calmare brings CTT to the forefront in meeting the needs of patients in distress and improving palliative healthcare globally."

RF|Binder will be leading an online and traditional media relations campaign to gain exposure for the innovative Calmare Therapy Treatment. For more information about the device, visit www.CalmareTT.com.

About RF|Binder Partners

A member of the Ruder Finn Group, RF|Binder leverages a 60-year heritage of public relations expertise and creative approaches to focus on the changing needs of Fortune 1000 companies, start-ups, non-profit organizations and governments. Headquartered in New York City, RF|Binder Partners operates offices in Boston, Chicago, Los Angeles and Washington, D.C. and maintains affiliate relationships with a global network of full service communications agencies. For more information, please visit www.RFBinder.com.

About Competitive Technologies, Inc.

Competitive Technologies, established in 1968, provides distribution, patent and technology transfer, sales and licensing services focused on the needs of its customers and matching those requirements with commercially viable product or technology solutions. CTT is a global leader in identifying, developing and commercializing innovative products and technologies in life, electronic, nano and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: www.competitivetech.net.

* Calmare Therapy Treatment - Pain Management Therapy Unit Model: MC-5A

    For More Information Contact:

    Robert Ferris
    RF|Binder Partners
    212-994-7505
    Robert.Ferris@RFBinder.com

    Tara Maroney
    RF|Binder Partners
    212-994-7551
    Tara.Maroney@RFBinder.com

SOURCE RF|Binder Partners


'/>"/>
SOURCE RF|Binder Partners
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
2. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
3. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
4. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
5. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
6. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
7. New Clinical Studies Confirm Mauna Kea Technologies Cellvizio(R) GI in Range of Procedures
8. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
9. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
10. Senesco Technologies Initiates Preclinical Studies for Cancer Target
11. ASEAN News: Epeius Biotechnologies Gains Commercial Approval for Rexin-G(R), a Tumor-Targeted Gene-Based Medicine for Metastatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/5/2017)... July 5, 2017 Pace Analytical, a company of over 2,000 employees ... they have acquired ESC Lab Sciences, further solidifying their position as the top ... . ... President and CEO of Pace Analytical ... Sciences out of Mt Juliet, TN , enhances Pace Analytical,s ...
(Date:6/30/2017)... June 30, 2017 In vitro diagnostics market ... of May, at least ten diagnostic companies have successfully ... public offerings and a loan facility.  The size of ... $80 million.  Kalorama Information provides a monthly IVD ... Diagnostics Knowledge Center. ...
(Date:6/27/2017)... June 27, 2017  Therapix Biosciences Ltd. (Nasdaq: ... specializing in the development of cannabinoid-based drugs, today announced ... Opening Bell in New York, NY ... its initial public offering (IPO) of American Depository Shares ... 2017. Dr. Elran Haber, Ph.D., Chief Executive ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 21, 2017 , ... West Dermatology is pleased to announce the newest addition ... 2017, Ms. Vu will join West Dermatology’s large network of medical and cosmetic dermatology ... cancer , and more. She graduated from the University of Florida College of Medicine ...
(Date:7/20/2017)... ... July 20, 2017 , ... TransPixel Volume 2 is a set ... the FCPX timeline. This effect isolates horizontal and vertical lines of pixels and sorts ... a rotating or flipping animation and can be changed using a drop-down menu. Create ...
(Date:7/20/2017)... ... July 20, 2017 , ... Coats Rose, P.C. , ... announce their expansion to the Midwest with the establishment of the firm’s new ... Bell, and of counsels, John Peck and Robert Bruns, will establish and anchor ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading network of ... Chiropractic , directed by Dr. Russell Horine, DC to their exclusive list of medical ... Dr. Russell Horine serving as the clinic director and his son Dr. Lee Horine ...
(Date:7/20/2017)... ... 2017 , ... The Dermatology Clinic announced today the addition of Dr. Scott ... from LSU, graduating summa cum laude. He attended Emory University School of Medicine in ... Louis, Dr. Dunbar moved to New York to complete an AGCME-accredited Mohs surgery fellowship ...
Breaking Medicine News(10 mins):